See more : Crown PropTech Acquisitions Red (CPTK-WT) Income Statement Analysis – Financial Results
Complete financial analysis of Innovative Pharmaceutical Biotech Limited (0399.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Innovative Pharmaceutical Biotech Limited, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Dusk Group Limited (DSK.AX) Income Statement Analysis – Financial Results
- Electrolux Professional AB (publ) (EPRO-B.ST) Income Statement Analysis – Financial Results
- Lifco AB (publ) (LIFCO-B.ST) Income Statement Analysis – Financial Results
- Amatheon Agri Holding N.V. (MLAAH.PA) Income Statement Analysis – Financial Results
- Greattown Holdings Ltd. (600094.SS) Income Statement Analysis – Financial Results
Innovative Pharmaceutical Biotech Limited (0399.HK)
About Innovative Pharmaceutical Biotech Limited
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.59M | 8.08M | 11.15M | 15.19M | 14.58M | 18.59M | 15.81M | 9.19M | 19.91M | 33.98M | 36.18M | 10.05M | 25.48M | 90.19M | 483.95M | 374.44M | 317.04M | 83.11M | 32.03M | 29.06M | 29.09M |
| Cost of Revenue | 5.75M | 7.22M | 10.09M | 13.78M | 12.96M | 16.84M | 14.42M | 8.46M | 19.32M | 33.06M | 37.00M | 18.06M | 10.44M | 56.69M | 442.97M | 362.90M | 308.93M | 78.82M | 27.82M | 25.62M | 26.54M |
| Gross Profit | 840.00K | 858.00K | 1.05M | 1.41M | 1.62M | 1.75M | 1.40M | 727.00K | 589.00K | 918.00K | -812.50K | -8.01M | 15.04M | 33.51M | 40.98M | 11.55M | 8.11M | 4.29M | 4.21M | 3.44M | 2.56M |
| Gross Profit Ratio | 12.74% | 10.63% | 9.46% | 9.25% | 11.11% | 9.40% | 8.82% | 7.91% | 2.96% | 2.70% | -2.25% | -79.69% | 59.03% | 37.15% | 8.47% | 3.08% | 2.56% | 5.17% | 13.14% | 11.85% | 8.79% |
| Research & Development | 1.42M | 4.76M | 8.25M | 6.09M | 11.34M | 1.93M | 665.00K | 629.00K | 1.35M | 5.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 12.92M | 17.03M | 17.24M | 16.91M | 22.64M | 26.74M | 25.75M | 22.56M | 30.01M | 27.89M | 36.09M | 49.68M | 55.68M | 27.35M | 18.03M | 28.24M | 10.14M | 4.62M | 2.96M | 6.39M | 53.33M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 195.00K | 248.00K | 0.00 | 944.00K | 1.52M | 2.44M | 2.64M | 9.71M | 2.42M | 6.64M | 3.67M | 4.27M | 3.02M | 2.61M |
| SG&A | 12.92M | 17.03M | 17.24M | 16.91M | 22.64M | 26.74M | 25.75M | 22.75M | 30.26M | 27.89M | 37.03M | 51.19M | 58.11M | 29.99M | 27.74M | 30.66M | 16.78M | 8.29M | 7.23M | 9.41M | 55.94M |
| Other Expenses | 0.00 | 1.00K | 80.00K | -212.00K | 9.00K | 0.00 | 3.00K | 166.00K | -5.07M | -10.49M | 0.00 | -11.38M | -937.00K | 161.00K | -247.00K | -631.56M | -71.00K | -30.00K | -9.00K | -818.00K | -8.26M |
| Operating Expenses | 14.27M | 21.56M | 25.49M | 22.79M | 33.98M | 28.68M | 26.41M | 23.38M | 31.61M | 33.19M | 570.51M | 51.19M | 57.18M | 24.81M | 27.49M | -600.90M | 16.71M | 8.26M | 7.22M | 8.59M | 47.68M |
| Cost & Expenses | 20.03M | 28.78M | 35.58M | 36.57M | 46.94M | 45.52M | 40.83M | 31.84M | 50.93M | 66.25M | 607.51M | 69.25M | 67.61M | 81.50M | 470.46M | -238.01M | 325.64M | 87.08M | 35.05M | 34.21M | 74.22M |
| Interest Income | 0.00 | 233.97M | 3.00K | 29.00K | 21.00K | 1.99M | 9.50M | 11.50M | 12.86M | 4.07M | 480.00K | 6.09M | 6.13M | 1.64M | 0.00 | 0.00 | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 218.10M | 233.97M | 189.95M | 191.03M | 147.04M | 131.69M | 110.73M | 108.03M | 79.56M | 52.94M | 0.00 | 938.00K | 150.00K | 359.00K | 184.00K | 633.00K | 59.99M | 60.46M | 49.93M | 0.00 | 0.00 |
| Depreciation & Amortization | 941.00K | 1.88M | 2.13M | 2.31M | 1.24M | 67.00K | 617.00K | 1.17M | 1.16M | 1.29M | 5.81M | 11.79M | 100.65M | 1.97M | 456.00K | 1.19M | 3.08M | 3.14M | 2.70M | 2.56M | 2.06M |
| EBITDA | 317.75M | -18.82M | -22.31M | -18.81M | -80.49M | -129.15M | -119.65M | -69.14M | -160.22M | -402.69M | -32.03M | -37.18M | -125.35M | 10.83M | 13.95M | 748.06M | -5.52M | -833.00K | 881.00K | -2.59M | -43.06M |
| EBITDA Ratio | 4,819.43% | -233.08% | -199.40% | -125.31% | -169.91% | -62.11% | -39.67% | 3.71% | -70.11% | -109.23% | -88.53% | -528.04% | 253.74% | 12.01% | 2.88% | 199.81% | -1.74% | -1.00% | -0.99% | -8.92% | -148.03% |
| Operating Income | -13.43M | -20.70M | -24.35M | -21.34M | -26.02M | -11.61M | -6.89M | -830.00K | -23.07M | -38.88M | -37.85M | -88.78M | -131.61M | 8.70M | 13.49M | 612.45M | -8.60M | -3.97M | -3.02M | -5.15M | -45.13M |
| Operating Income Ratio | -203.76% | -256.37% | -218.51% | -140.51% | -178.44% | -62.47% | -43.57% | -9.03% | -115.87% | -114.43% | -104.59% | -883.37% | -516.61% | 9.64% | 2.79% | 163.56% | -2.71% | -4.78% | -9.42% | -17.72% | -155.11% |
| Total Other Income/Expenses | 112.14M | -233.97M | 60.79M | -190.77M | -190.10M | -233.98M | -205.97M | -155.69M | -209.93M | -424.64M | -533.96M | -594.00K | -90.23M | 161.00K | -184.00K | 133.88M | -59.95M | -60.46M | -49.93M | -35.85M | -1.41B |
| Income Before Tax | 98.71M | -254.67M | 36.43M | -212.16M | -222.46M | -260.91M | -230.99M | -178.34M | -240.95M | -456.91M | -571.80M | -89.72M | -131.76M | 8.86M | 13.31M | 746.33M | -68.55M | -64.43M | -52.95M | -41.00M | -1.46B |
| Income Before Tax Ratio | 1,497.15% | -3,153.82% | 326.88% | -1,396.77% | -1,525.80% | -1,403.58% | -1,460.95% | -1,941.24% | -1,210.30% | -1,344.81% | -1,580.24% | -892.71% | -517.20% | 9.82% | 2.75% | 199.32% | -21.62% | -77.52% | -165.33% | -141.07% | -5,006.92% |
| Income Tax Expense | 0.00 | -8.97M | -260.11M | 183.60M | 185.10M | 116.97M | 113.43M | 60.92M | 142.18M | 360.35M | -2.50M | -60.00K | -2.06M | 3.25M | 2.13M | 1.09M | 33.00K | 10.00K | 49.94M | 35.85M | 1.41B |
| Net Income | 103.40M | -245.70M | 296.54M | -395.75M | -407.56M | -260.27M | -231.05M | -169.79M | -236.87M | -451.68M | -569.30M | -72.84M | -123.88M | 5.25M | 11.26M | 745.21M | -68.62M | -64.05M | -52.95M | -41.00M | -1.46B |
| Net Income Ratio | 1,568.38% | -3,042.70% | 2,660.73% | -2,605.52% | -2,795.35% | -1,400.14% | -1,461.31% | -1,848.13% | -1,189.80% | -1,329.42% | -1,573.33% | -724.77% | -486.29% | 5.82% | 2.33% | 199.02% | -21.64% | -77.07% | -165.33% | -141.07% | -5,006.92% |
| EPS | -0.01 | -0.17 | 0.20 | -0.27 | -0.28 | -0.18 | -0.16 | -0.12 | -0.17 | -0.36 | -0.55 | -0.09 | -0.18 | 0.01 | 0.02 | 1.46 | -3.29 | -3.07 | -2.54 | -1.96 | -72.17 |
| EPS Diluted | -0.01 | -0.17 | 0.17 | -0.27 | -0.28 | -0.18 | -0.16 | -0.12 | -0.17 | -0.36 | -0.55 | -0.09 | -0.18 | 0.01 | 0.02 | 1.46 | -3.29 | -3.07 | -2.54 | -1.96 | -72.17 |
| Weighted Avg Shares Out | 1.53B | 1.46B | 1.46B | 1.46B | 1.46B | 1.46B | 1.46B | 1.46B | 1.41B | 1.26B | 1.04B | 776.50M | 685.30M | 639.87M | 545.49M | 509.27M | 20.84M | 20.84M | 20.84M | 20.89M | 20.18M |
| Weighted Avg Shares Out (Dil) | 2.50B | 1.46B | 1.75B | 1.46B | 1.46B | 1.46B | 1.46B | 1.46B | 1.41B | 1.26B | 1.04B | 776.74M | 685.30M | 639.87M | 545.49M | 509.27M | 20.84M | 20.84M | 20.84M | 20.89M | 20.18M |
Source: https://incomestatements.info
Category: Stock Reports